Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 22;10(1):10.
doi: 10.1186/s13073-018-0524-7.

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

Antoinette MaassenVanDenBrink  1 , Gisela M Terwindt  2 , Arn M J M van den Maagdenberg  3   4
Affiliations

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

Antoinette MaassenVanDenBrink et al. Genome Med. .

Abstract

Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.

PubMed Disclaimer

Conflict of interest statement

Competing interests

AMVDB has obtained research grants from Amgen/Novartis and Lilly. GMT reports consultancy support from Novartis and Lilly. AMJMvdM declares that he has no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553–622. doi: 10.1152/physrev.00034.2015. - DOI - PMC - PubMed
    1. Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14:65–80. doi: 10.1016/S1474-4422(14)70220-0. - DOI - PubMed
    1. Edvinsson L. The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache. 2017;57(Suppl 2):47–55. doi: 10.1111/head.13081. - DOI - PubMed
    1. Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, et al. Blocking CGRP in migraine patients—a review of pros and cons. J Head Pain. 2017;18:96. doi: 10.1186/s10194-017-0807-1. - DOI - PMC - PubMed
    1. Goadsby PJ, Reuter U, Hallström Y, Broesner G, Bonner JH, Zhang F, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017;377:2123–2132. doi: 10.1056/NEJMoa1705848. - DOI - PubMed

Publication types

MeSH terms

Substances